The diagnosis of the disease still remains probable and only post-mortem biopsy can confirm AD as it reveals deposits of amyloid-β (Aβ) plaque deposition and tau protein (NFTs) in the brain tissue (Braak and Braak, 1997a). The gene discussed is MAPT; the disease is Alzheimer disease.